Company / Cost of Revenue
CorMedix Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$22.1M
FY2025
5-year range
$148.9K / $22.1M
FY2021-FY2025
Trend
+628.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue changed +628% YoY in FY2025, a notable deviation from the 8-year average annual change of +356%.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +126.2%.
Increased from $148,938 to $22M over the past 3 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +429.3%
- 5-Year CAGR
- +126.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +126.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 628.0% year-over-year.
- Lowest cost of revenue in the period was in FY2016.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.1M | +628.0% |
| FY2024 | $3.0M | - |
| FY2023 | - | - |
| FY2022 | $148.9K | -27.3% |
| FY2021 | $204.8K | -45.1% |
| FY2020 | $373.2K | -5.9% |
| FY2019 | $396.8K | +245.1% |
| FY2018 | $115.0K | -68.6% |
| FY2017 | $366.7K | +182.3% |
| FY2016 | -$445.8K | -39.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026